Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    • Part of brands: |
    InternationalInternational
    • Country/Region
      • Part of brands: |
      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      Genomics Precision Diagnostic > Neurology Precision Panel > Spinocerebellar Ataxia Precision Panel

      Spinocerebellar Ataxia Precision Panel

      Spinocerebellar Ataxia (SCA) refers to a heterogeneous group of progressive neurodegenerative diseases of genetic origin. Currently, more than 30 types have been described, most of which are autosomal dominant. Classification is done according to the clinical manifestations or genetic nosology. 
      Overview
      Indication
      Clinical Utility
      Genes & Diseases
      Methodology
      References

      Overview

      • Spinocerebellar Ataxia (SCA) refers to a heterogeneous group of progressive neurodegenerative diseases of genetic origin. Currently, more than 30 types have been described, most of which are autosomal dominant. Classification is done according to the clinical manifestations or genetic nosology. The most common type is SCA3. Ataxia is defined as the absence of voluntary muscle coordination and loss of control of movement affecting gait stability, eye movement and speech. The clinical hallmark of SCA is loss of balance and coordination accompanied by slurred speech; onset is most often in adult life. The main disease mechanism of these SCAs include toxic RNA gain-of-function, mitochondrial dysfunction, channelopathies, autophagy and transcription dysregulation. The prognosis is dependent upon the individual and genetic properties, but most patients develop severe, irreversible disability, while retaining full mental capacity.

      • The Igenomix Spinocerebellar Ataxia Precision Panel can be used as a tool for an accurate diagnosis and differential diagnosis of loss of balance and coordination ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved, and their high or intermediate penetrance.

      Indication

      • The Igenomix Spinocerebellar Ataxia Precision Panel is used for patients with a clinical suspicion or diagnosis presenting with or without the following symptoms: 
        • Broad based gait ataxia 
        • Tremor 
        • Limb ataxia 
        • Nystagmus 
        • Difficulty speaking 
        • Decreased coordination 
        • Dementia 

      Clinical Utility

      The clinical utility of this panel is: 

      • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.   
      • Early initiation of treatment involving a multidisciplinary team in the form of orthopaedic care, use of special devices to assist with fine movements as 
      • Risk assessment of asymptomatic family members according to the mode of inheritance via genetic counselling.  
      • Improvement of delineation of genotype-phenotype correlation given the variability of severity and course of disease.  

      Genes & Diseases

      Methodology

      References

      See scientific referrals

      Sullivan, R., Yau, W. Y., O’Connor, E., & Houlden, H. (2019). Spinocerebellar ataxia: an update. Journal of neurology, 266(2), 533–544. https://doi.org/10.1007/s00415-018-9076-4 

      Klockgether, T., Mariotti, C., & Paulson, H. L. (2019). Spinocerebellar ataxia. Nature reviews. Disease primers, 5(1), 24. https://doi.org/10.1038/s41572-019-0074-3 

      Sun, Y. M., Lu, C., & Wu, Z. Y. (2016). Spinocerebellar ataxia: relationship between phenotype and genotype – a review. Clinical genetics, 90(4), 305–314. https://doi.org/10.1111/cge.12808 

      Soong, B. W., & Morrison, P. J. (2018). Spinocerebellar ataxias. Handbook of clinical neurology, 155, 143–174. https://doi.org/10.1016/B978-0-444-64189-2.00010-X 

      Manto, M. (2005). The wide spectrum of spinocerebellar ataxias (SCAs). The Cerebellum, 4(1), 2-6. doi: 10.1080/14734220510007914 

      Spinocerebellar ataxia. (2019). Nature reviews. Disease primers, 5(1), 25. https://doi.org/10.1038/s41572-019-0081-4 

      Coarelli, G., Brice, A., & Durr, A. (2018). Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view. F1000Research, 7, F1000 Faculty Rev-1781. https://doi.org/10.12688/f1000research.15788.1 

      descargar

      Detail description

      Download

      Request Information


      WE GUIDE YOU

      Fertility
      Inherited diseases prevention
      Healthy pregnancy

      To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

      OUR SERVICES

      Genetic solutions
      For patients
      How to send a sample?
      User manual

      ABOUT US

      About Igenomix
      Contact
      Quality
      Complaints
      Work with us

      FOLLOW IGENOMIX

        + 96 390 53 10
        Write us
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Europe
      • France
      • Germany
      • India
      • Italy
      • Japan
      • Korea
      • Mexico
      • Perú
      • Russia
      • Spain
      • Taiwan
      • The Middle East
      • Turkey
      • United Kingdom
      • United States
      • Vietnam
      Country/Region

      [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

      Request Information

















      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      • Country/Region
      • +34 96 390 53 10
      • Clinic Portal
      • Request Information

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in settings.

      International
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      3rd Party Cookies

      This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

      Keeping this cookie enabled helps us to improve our website.

      Please enable Strictly Necessary Cookies first so that we can save your preferences!

      Cookie Policy

      More information about our Cookie Policy